Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Role of Neuromodulation Technique In Depression Disorder
NCT05047159Unknown
- Sponsor
- Shanghai Mental Health Center
- Start
- Nov 2022
- Primary completion
- Mar 2024
- Countries
- 1
01
Overview
Randomised trial in major depressive disorder (MDD) (5 arms), sponsored by Shanghai Mental Health Center. Primary endpoint: Change of the 17-item Hamilton Depression Scale Score at 48 weeks. Status: unknown.
02
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT05047159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05047159.